TG Therapeutics Inc TGTX shares are trading higher by $0.03 at $5.03 in Wednesday's session. The issue was trading much higher earlier in the session following the announcement of positive Multiple Sclerosis study data.
The news, which came before the open, pushed the issue passed the trio of highs at $5.10 from the last last three sessions, making an early morning high $0.10 above its opening price ($5.40) at $5.50. That high just exceeds its December 9 high of $5.47.
However, some profit-takers immediately surfaced and sent the issue a couple cents below its closing price of $4.95, so far finding support at $4.93. At this time, it's attempting to remain in the $5.00 handle. If the can close above $5, it will be the first time since December 12, when it ended that session at $5.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
